Core Viewpoint - The company intends to sign a related party transaction contract with China Life Insurance Group and its subsidiaries, with a total contract amount of 8.7 million yuan (including VAT) for the "China Life New Generation Human Resource Management System Phase II Project" [1][2] Summary by Sections Related Party Transaction Overview - The contract amount for the related party transaction is 8.7 million yuan (including VAT) [1] - The transaction involves multiple entities under China Life Insurance Group, including China Life Insurance Co., Ltd. and its subsidiaries [2] Related Party Identification and Relationship - China Life Insurance Group holds 20.34% of the company's shares, making it the largest shareholder [2] - The transaction is classified as a related party transaction under the Shenzhen Stock Exchange regulations [2] Transaction Amount and Approval Process - Cumulative related party transaction amounts since December 27, 2024, including this transaction, total 20,848,613 yuan, exceeding 0.5% of the company's latest audited net assets [3] - The board of directors approved the transaction on June 19, 2025, with independent directors unanimously agreeing to the proposal [3][14] Pricing Policy and Agreement Details - The transaction follows normal commercial practices, with pricing determined based on market standards, ensuring fairness and reasonableness [10][13] - The contract stipulates payment in four installments, totaling 8.7 million yuan, with specific conditions for each payment [11][12] Purpose and Impact on the Company - The transaction is deemed necessary for the company's operational activities and will not significantly impact its business independence or financial condition [13] - The total amount of related party transactions for the year to date is 9,459,817.37 yuan [13] Review Procedures - Independent directors and the board of supervisors have reviewed and approved the transaction, confirming compliance with relevant laws and regulations [14][15]
万达信息: 太平洋证券股份有限公司关于万达信息股份有限公司拟签订关联交易合同的核查意见